These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3816112)

  • 1. Indocyanine green plasma clearance as a measure of changes in hepatic blood flow.
    Kanstrup IL; Winkler K
    Clin Physiol; 1987 Feb; 7(1):51-4. PubMed ID: 3816112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of dye infusion rate and hepatic plasma flow on indocyanine green clearance.
    Krarup N; Larsen JA
    Scand J Clin Lab Invest; 1976 Mar; 36(2):183-8. PubMed ID: 1273495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of hepatic blood flow in healthy subjects by continuous infusion of indocyanine green.
    Soons PA; De Boer A; Cohen AF; Breimer DD
    Br J Clin Pharmacol; 1991 Dec; 32(6):697-704. PubMed ID: 1768562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension.
    Berzigotti A; Reverter E; García-Criado A; Abraldes JG; Cerini F; García-Pagán JC; Bosch J
    J Hepatol; 2013 Oct; 59(4):717-22. PubMed ID: 23669282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic blood flow determination. A comparison of 99mTc-diethyl-IDA and indocyanine green as hepatic blood flow indicators in man.
    Henriksen JH; Winkler K
    J Hepatol; 1987 Feb; 4(1):66-70. PubMed ID: 3571934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The organ extraction and splanchnic haemodynamic effects of octreotide in cirrhotic patients.
    Ottesen LH; Flyvbjerg A; Møller S; Bendtsen F
    Aliment Pharmacol Ther; 1998 Jul; 12(7):657-65. PubMed ID: 9701530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man.
    Skak C; Keiding S
    Liver; 1987 Jun; 7(3):155-62. PubMed ID: 3613884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man.
    Grainger SL; Keeling PW; Brown IM; Marigold JH; Thompson RP
    Clin Sci (Lond); 1983 Feb; 64(2):207-12. PubMed ID: 6822056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of liver blood flow and function on hepatic indocyanine green clearance measured directly in a cirrhotic animal model.
    Jiao LR; El-Desoky AA; Seifalian AM; Habib N; Davidson BR
    Br J Surg; 2000 May; 87(5):568-74. PubMed ID: 10792311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
    Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
    Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic blood flow measurements and indocyanine green kinetics in a chronic dog model.
    Skerjanec A; O'Brien DW; Tam TK
    Pharm Res; 1994 Nov; 11(11):1511-5. PubMed ID: 7870662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between hepatic blood flow, liver tests, haemodynamic values and clinical characteristics in patients with chronic liver disease.
    Gadano A; Hadengue A; Vachiery F; Moreau R; Sogni P; Soupison T; Yang S; Cailmail S; Lebrec D
    J Gastroenterol Hepatol; 1997 Feb; 12(2):167-71. PubMed ID: 9083919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic drug clearance: the effect of age using indocyanine green as a model compound.
    Wynne HA; Goudevenos J; Rawlins MD; James OF; Adams PC; Woodhouse KW
    Br J Clin Pharmacol; 1990 Oct; 30(4):634-7. PubMed ID: 2291878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiorthostatic bed rest on hepatic blood flow in man.
    Putcha L; Cintron NM; Vanderploeg JM; Chen Y; Habis J; Adler J
    Aviat Space Environ Med; 1988 Apr; 59(4):306-8. PubMed ID: 3370038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green.
    Uusaro A; Ruokonen E; Takala J
    Cardiovasc Res; 1995 Jul; 30(1):106-12. PubMed ID: 7553712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of indocyanine green in rats with experimentally induced hepatic diseases.
    Kimura T; Nakayama S; Yamao T; Kurosaki Y; Nakayama T
    Biol Pharm Bull; 1993 Nov; 16(11):1140-5. PubMed ID: 8312872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of multiple doses of cimetidine on estimated hepatic blood flow.
    Grasela DM; Rocci ML; Rotmensch HH; Vlasses PH
    Biopharm Drug Dispos; 1987; 8(1):63-72. PubMed ID: 3580514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No effect of diltiazem on the hepatic clearance of indocyanine green in the rats.
    Joo EH; Lee YB
    Arch Pharm Res; 1998 Aug; 21(4):411-7. PubMed ID: 9875468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic blood flow: accuracy of estimation from infusions of indocyanine green in anaesthetized cats.
    Burczynski FJ; Greenway CV; Sitar DS
    Br J Pharmacol; 1987 Jul; 91(3):651-9. PubMed ID: 3607371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of bolus and infusion methods for estimating hepatic blood flow in patients with liver disease using indocyanine green.
    Clements D; West R; Elias E
    J Hepatol; 1987 Dec; 5(3):282-7. PubMed ID: 3429835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.